The development of a novel drug delivery system for the treatment of inflammatory bowel disease
The project concerns the development of a drug delivery system for the treatment of inflammatory bowel disease. This condition, which affects more than 2 million people in Europe alone, is characterised by inflammatory lesions which may be confined to the large bowel (ulcerative colitis) or extend t...
Main Author: | McBride, Eileen |
---|---|
Published: |
University of Strathclyde
2008
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.501659 |
Similar Items
-
The pharmacogenetics of azathioprine toxicity and efficiency in inflammatory bowel disease
by: Wright, Samantha
Published: (2004) -
Genetic variants influencing susceptibility to inflammatory bowel disease and its natural history
by: McGovern, Dermot P. B.
Published: (2006) -
Culture, healing practice pluralism and living with inflammatory bowel disease
by: Philipp, Lynn
Published: (2012) -
Assessment of MHC haplotype in early-onset inflammatory bowel disease
by: Mathers, H. M. C.
Published: (2005) -
Characterisation of mucosa-associated Escherichia coli in inflammatory bowel disease and colon cancer
by: Martin, Helen Mary
Published: (2003)